BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, April 10, 2026
Home » Topics » Analysis and data insight, Medical technology

Analysis and data insight, Medical technology
Analysis and data insight, Medical technology RSS Feed RSS

Med-tech gainers and losers for Nov. 20-24, 2023

Nov. 27, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Nov. 13-17, 2023

Nov. 20, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Nov. 6-10, 2023

Nov. 13, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More
Med-tech deals October 2023

Med-tech M&As continue decline while deal value soars nearly 50% YOY

Nov. 10, 2023
By Amanda Lanier
While med-tech deals were well below average the past two months, cumulative values are up 47.67% over the same period last year. Through October, the total worth of med-tech deals reached $9.97 billion, rising from $6.75 billion in the corresponding period in 2022.
Read More

Med-tech gainers and losers for Oct. 30-Nov. 3, 2023

Nov. 6, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More
Stock chart, red down arrow
Med-tech financings October 2023

Up from September low, med-tech financings down nearly 42% for the year

Nov. 3, 2023
By Amanda Lanier
Med-tech saw some good news in October, with total financings value reaching $1.22 billion, an increase of 89.23% from the $645.75 million in September. However, the increase didn’t make up for the broader year-over-year decline in med-tech investments.
Read More

Med-tech gainers and losers for Oct. 23-27, 2023

Oct. 30, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Oct. 16-20, 2023

Oct. 23, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Oct. 9-13, 2023

Oct. 16, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More
Med-tech deals September 2023

Despite September slowdown, med-tech deal value hits $9.83B through Q3

Oct. 16, 2023
By Amanda Lanier
Med-tech deals are up 49.01% year over year, with the industry raising $9.83 billion through September in 2023, up from $6.59 billion in the same time frame last year. The number of deals, meanwhile, has decreased from 1,510 through Q3 2022 to 1,278 this year.
Read More
Previous 1 2 … 19 20 21 22 23 24 25 26 27 … 54 55 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 10, 2026.
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • Connecting puzzle pieces

    Korsana boosts Alzheimer’s work with reverse merger, $380M financing

    BioWorld Science
    Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing